Sanders Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27B | Buy |
|
|||||
|
2025
Q1 | $2.03B | Sell |
|
|||||
|
2024
Q4 | $1.73B | Buy |
|
|||||
|
2024
Q3 | $2.4B | Buy |
|
|||||
|
2024
Q2 | $2.47B | Buy |
|
|||||
|
2024
Q1 | $2.34B | Buy |
|
|||||
|
2023
Q4 | $2.1B | Buy |
|
|||||
|
2023
Q3 | $1.86B | Buy |
|
|||||
|
2023
Q2 | $1.87B | Buy |
|
|||||
|
2023
Q1 | $1.85B | Buy |
|
|||||
|
2022
Q4 | $1.99B | Sell |
|
|||||
|
2022
Q3 | $1.8B | Sell |
|
|||||
|
2022
Q2 | $1.97B | Sell |
|
|||||
|
2022
Q1 | $2.01B | Buy |
|
|||||
|
2021
Q4 | $1.87B | Buy |
|
|||||
|
2021
Q3 | $1.48B | Buy |
|
|||||
|
2021
Q2 | $1.39B | Buy |
|
|||||
|
2021
Q1 | $1.26B | Buy |
|
|||||
|
2020
Q4 | $1.11B | Buy |
|
|||||
|
2020
Q3 | $824M | Buy |
|
|||||
|
2020
Q2 | $745M | Buy |
|
|||||
|
2020
Q1 | $615M | Buy |
|
|||||
|
2019
Q4 | $791M | Buy |
|
|||||
|
2019
Q3 | $551M | Buy |
|
|||||
|
2019
Q2 | $620M | Buy |
|
|||||
|
2019
Q1 | $573M | Buy |
|
|||||
|
2018
Q4 | $479M | Buy |
|
|||||
|
2018
Q3 | $495M | Sell |
|
|||||
|
2018
Q2 | $447M | Buy |
|
|||||
|
2018
Q1 | $412M | Sell |
|
|||||
|
2017
Q4 | $423M | Buy |
|
|||||
|
2017
Q3 | $349M | Sell |
|
|||||
|
2017
Q2 | $379M | Sell |
|
|||||
|
2017
Q1 | $375M | Sell |
|
|||||
|
2016
Q4 | $370M | Buy |
|
|||||
|
2016
Q3 | $295M | Sell |
|
|||||
|
2016
Q2 | $375M | Sell |
|
|||||
|
2016
Q1 | $403M | Buy |
|
|||||
|
2015
Q4 | $347M | Buy |
|
|||||
|
2015
Q3 | $279M | Buy |
|
|||||
|
2015
Q2 | $327M | Sell |
|
|||||
|
2015
Q1 | $308M | Sell |
|
|||||
|
2014
Q4 | $259M | Buy |
|
|||||
|
2014
Q3 | $245M | Sell |
|
|||||
|
2014
Q2 | $242M | Sell |
|
|||||
|
2014
Q1 | $283M | Sell |
|
|||||
|
2013
Q4 | $281M | Buy |
|
|||||
|
2013
Q3 | $243M | Sell |
|
|||||
|
2013
Q2 | $253M | Buy |
|